SuperworthAbeona Therapeutics shares outstanding ABEO
Diluted shares outstanding, averaged over each quarter, from 2010.
- Latest quarter, to Jun 30, 2026
- 57M
- On a year earlier
- −14.4%
- fewer shares
Abeona Therapeutics had 57M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 14.4% fewer than a year earlier, so each share owns a little more of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 55.2M | +14% |
| FY2024 | 48.6M | +90% |
| FY2023 | 25.6M | +92% |
| FY2022 | 13.4M | +219% |
| FY2021 | 4.2M | +13% |
| FY2020 | 3.7M | +70% |
| FY2019 | 2.2M | +14% |
| FY2018 | 1.9M | +5% |
| FY2017 | 1.8M | +20% |
| FY2016 | 1.5M | +16% |
| FY2015 | 1.3M | +6290% |
| FY2013 | 20.5K | +5% |
| FY2012 | 19.4K | +12% |
| FY2011 | 17.4K | +32% |
| FY2010 | 13.2K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 57M | −14% | |
| Q1 FY26 | 56.6M | +14% | |
| Q4 FY25 | 55.2M | +14% | |
| Q3 FY25 | 54.2M | +13% | |
| Q2 FY25 | 66.6M | +30% | |
| Q1 FY25 | 49.8M | +82% | |
| Q4 FY24 | 48.6M | +90% | |
| Q3 FY24 | 48.1M | +94% | |
| Q2 FY24 | 51.2M | +184% | |
| Q1 FY24 | 27.3M | +62% | |
| Q4 FY23 | 25.6M | +92% | |
| Q3 FY23 | 24.8M | +286% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Abeona Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.